SEC Filing Details
Document Details
Form
Filing Date
Oct 13, 2021
Document Date
Oct 13, 2021
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
BioLineRx
Issuer
BioLineRx Ltd.
Press Releases View all
August 16, 2022
BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022
BioLineRx to Report Second Quarter 2022 Results on August 16, 2022